Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Pancreatic lesions
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Pancreatic solid lesions differential''' == * '''Neoplastic''' ** Pancreatic ductal adenocarcinoma ** Acinar cell carcinoma ** Endocrine tumours - PNETs - functional and non-functional * '''Non-neoplastic''' ** Focal pancreatitis, including autoimmune ** Fatty infiltration-replacement ** Intra-pancreatic accessory spleen ** Peri-pancreatic lymph node ** Congenital abnormalities - prominent lobulations, bifid pancreatic tail ** Sarcoidosis ** Castleman disease '''Key demographic and clinical features of patients with pancreatic cystic neoplasms[1-4]''' {| class="wikitable" | |'''Serous cystadenoma''' |'''Mucinous cystic neoplasm''' |'''Main-duct intraductal papillary mucinous neoplasm''' |'''Branch-duct intraductal papillary mucinous neoplasm''' |'''Solid pseudopapillary neoplasm''' |- |'''Age of presentation''' |Variable, usually 5th to 7th decade |Variable, usually 5th to 7th decade |Variable, usually 5th to 7th decade |Variable, usually 5th to 7th decade |Usually 2nd to 3rd decade |- |'''Gender distribution''' |Females >males |Exclusively females |Females = males |Females = males |Females >males |- |'''Typical clinical presentation''' |Incidental, less commonly abdominal pain or mass effect |Incidental, less commonly abdominal pain or malignancy related |Incidental or pancreatitis or pancreatic insufficiency or malignancy related |Incidental, less commonly pancreatitis or malignancy related |Incidental or abdominal pain or mass effect |- |'''Typical imaging characteristics''' |Microcystic/honeycomb appearance Oligocystic appearance less common May have central scar or calcification |Unilocular or septated cyst Β± wall calcifications Solid component, if present, may suggest malignancy |Dilated main pancreatic duct Β± parenchymal atrophy Solid component, if present, may suggest malignancy |Dilated pancreatic duct branch or branches Solid component, if present, may suggest malignancy |Solid and cystic mass Β± calcifications |- |'''Typical aspirate characteristic''' |Thin, often bloody |Viscous |Viscous |Viscous or thin |Bloody |- |'''Typical cytology findings''' |Cuboidal cells that stain positive for glycogen; yield <50% |Columnar cells with variable atypia Stains positive for mucin; yield <50% High yield from solid component for malignancy |Columnar cells with variable atypia Stains positive for mucin; yield <50% High yield from solid component for malignancy |Columnar cells with variable atypia Stains positive for mucin; yield <50% High yield from solid component for malignancy |Characteristic branching papillae with myxoid stroma High yield from solid component |- |'''Typical carcinoembryonic antigen (CEA) level''' |<5 to 20 ng/mL in majority of lesions |>200 ng/mL in approximately 75% of lesions |Typically elevated (limited data) |>200 ng/mL in approximately 75% of lesions |Insufficient data |- |'''Typical glucose level''' |>50 mg/dL in majority |<50 mg/dL in majority |<50 mg/dL (limited data) |<50 mg/dL in majority |Insufficient data |- |'''Typical DNA analysis''' |VHL mutation specific |K-ras mutation specific (>90%), not sensitive (<50%) TP53, PTEN, PIK3CA mutations seen in malignancy |K-ras and GNAS mutation specific (>90%), not sensitive (<50%) TP53, PTEN, PIK3CA mutationsseen in malignancy |K-ras and GNAS mutation specific (>90%), not sensitive (<50%) TP53, PTEN, PIK3CA mutationsseen in malignancy |CTNNB1 mutation specific |- |'''Relative malignant potential''' |Negligible |Moderate |High |Low to moderate |Moderate to high |- |'''Treatment''' |Resect if symptomatic |Resection |Resection and post-resection surveillance |Monitor or resect Post-resection surveillance required |Resection |}
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Pancreatic lesions
(section)
Add topic